Vistin Pharma ASA
Saga Pure ASA has on 15 March 2021 sold 2,284,280 shares in Vistin Pharma ASA,
corresponding to 5.2% of the outstanding shares.
After the transaction, Saga Pure ASA has no holding of shares or votes in Vistin
Pharma ASA.
Attached is details of the transaction.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sanofi Winthrop Industrie20.10.2025 13:30:00 CEST | Press release
Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program
Pandora A/S20.10.2025 13:15:31 CEST | Press release
Transactions in connection with share buyback programme
Aktieselskabet Schouw & Co.20.10.2025 13:00:47 CEST | Press release
Schouw & Co. share buy-back programme, week 42 2025
SINTX Technologies, Inc.20.10.2025 13:00:00 CEST | Press release
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
Djurslands Bank A/S20.10.2025 12:45:48 CEST | Pressemeddelelse
Aktietilbagekøb i Djurslands Bank – transaktioner i uge 42
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom